Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial by Griesel, R, Zhao, Y, Simmons, B, Omar, Z, Wiesner, L, Keene, CM, Hill, AM, Meintjes, G, Maartens, G

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets by Bienczak, A, Denti, P, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Keketiinwa, A, Gibb, D, Burger, D, Walker, A, McIlleron, H

The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children by Bienczak, A, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Kekitiinwa, A, Walker, A, Owen, A, Gibb, D, Burger, D, McIlleron, H, Denti, P

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children by Bienczak, A, Cook, A, Wiesner, L, Olagunju, A, Mulenga, V, Kityo, C, Kekitiinwa, A, Owen, A, Walker, A, Gibb, D, McIlleron, H, Burger, D, Denti, P

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children. by Bienczak, A, Denti, P, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Kekitiinwa, A, Gibb, D, Burger, D, Walker, A, McIlleron, H, Chirehwa, M, Owen, A

Severe acute malnutrition results in lower lumefantrine exposure in children treated with artemether‐lumefantrine for uncomplicated malaria by Chotsiri, P, Denoeud-Ndam, L, Baudin, E, Guindo, O, Diawara, H, Attaher, O, Smit, M, Guerin, PJ, Doumbo, OK, Wiesner, L, Barnes, KI, Hoglund, RM, Dicko, A, Etard, J-F, Tarning, J

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen by Keene, CM, Griesel, R, Zhao, Y, Gcwabe, Z, Sayed, K, Hill, A, Cassidy, T, Ngwenya, O, Jackson, A, van Zyl, G, Schutz, C, Goliath, R, Flowers, T, Goemaere, E, Wiesner, L, Simmons, B, Maartens, G, Meintjes, G

Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger. by Denoeud-Ndam, L, Dicko, A, Baudin, E, Guindo, O, Grandesso, F, Diawara, H, Sissoko, S, Sanogo, K, Traoré, S, Keita, S, Barry, A, de Smet, M, Lasry, E, Smit, M, Wiesner, L, Barnes, K, Djimde, A, Guerin, P, Grais, R, Doumbo, O, Etard, J

UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria by Brunschwig, C, Lawrence, N, Taylor, D, Abay, E, Njoroge, M, Basarab, GS, Le Manach, C, Paquet, T, Cabrera, D, Nchinda, AT, de Kock, C, Wiesner, L, Denti, P, Waterson, D, Blasco, B, Leroy, D, Witty, MJ, Donini, C, Duffy, J, Wittlin, S, White, KL, Charman, SA, Jiménez-Díaz, MB, Angulo-Barturen, I, Herreros, E, Gamo, FJ, Rochford, R, Mancama, D, Coetzer, TL, van der Watt, ME, Reader, J, Birkholtz, L-M, Marsh, KC, Solapure, SM, Vanaerschot, M, Fidock, DA, Fish, PV, Siegl, P, Smith, DA, Wirjanata, G, Noviyanti, R, Price, RN, Marfurt, J, Silue, KD, Street, LJ, Chibale, K